Tuesday, February 16, 2021

New York State's new surrogacy law takes effect

NBC has the story:

No Longer an Outlier: New York Ends Commercial Surrogacy Ban.  New York's longstanding ban on commercial surrogate pregnancy is about to end nine years after a bill to rescind it was first introduced.    By David Crary

"Instead of being a national outlier, New York will become a leader, according to experts on surrogacy . They say the new law, passed in April and taking effect on Monday, has a surrogates’ bill of rights providing the nation’s strongest protections for women serving as surrogates.

"Among the provisions: the right to independent legal representation, a guarantee of comprehensive medical coverage, and the right to make their own health care decisions, including whether to terminate or continue a pregnancy.

“We went to California because it had the best laws,” Hoylman said. “Now New York has the best law. We think it’s a model for other states.”

"The new law allows gestational surrogacy on a commercial basis, involving a surrogate who is not genetically related to the embryo. An egg is removed from the intended mother, fertilized with sperm and then transferred to a surrogate — in contrast to so-called traditional surrogacy that involves an egg from the surrogate. The gestational option is welcomed by many LGBTQ people who want to be parents, as well as by couples struggling with infertility.

"With the change in New York, surrogacy advocates say only Louisiana and Michigan have laws explicitly prohibiting paid gestational surrogacy. Nebraska has no explicit ban, but a statute there says paid surrogacy contracts are unenforceable.

...

"Gestational surrogacy routinely costs between $100,000 and $150,000. Hoylman declined to estimate the total costs incurred by him and Sigal but said, “It was worth every penny.”

"Among the standard costs are fees for lawyers and the surrogacy agency, the cost of in vitro fertilization, plus compensation and health insurance for the surrogate. Compensation rates vary widely — generally $25,000 to $50,000.

"The first bill seeking to repeal the New York ban was introduced by Assemblywoman Amy Paulin in 2012, the year Hoylman was elected to the Senate. It floundered for years in the face of staunch opposition by the Roman Catholic Church and some feminists, who argued that paid surrogacy led to the exploitation of women.

“Under this bill, women in economic need become commercialized vessels for rent, and the fetuses they carry become the property of others,” renowned feminist Gloria Steinem wrote to lawmakers in 2019.

"New York Gov. Andrew Cuomo, who earlier in his tenure pushed hard to legalize same-sex marriage, argued in response that the surrogacy ban was “based in fear, not love” and was especially harmful to same-sex couples."


HT: Nick Arnosti.

**********

Here's a related story from the NY Times:

Meet the Women Who Become SurrogatesNew York State will now allow gestational surrogates to carry babies for other parents. Here’s why they do it.   By David Dodge

"In 1995, Lisa Wippler, having recently retired from the Marines, moved with her husband and two young sons to Oceanside, Calif., and was contemplating her next chapter in life. The answer came while lying in bed one night, reading an article about infertility.

...

"Last year, Ms. Wippler — by this point a three-time surrogate herself — was part of a delegation of surrogacy advocates who traveled to Albany, where she had the opportunity to share her story with lawmakers considering whether to legalize the practice in New York State.

...

"In her advocacy work, Ms. Wippler said, she has been befuddled to hear the arguments put forward by opponents — some of whom contend the surrogacy industry preys on poor and vulnerable women.

“I’m a retired Marine,” she said. “I can guarantee you no one coerced me.”

...

"A surrogate’s compensation varies by a number of factors, including geographic location and whether she is a first time or experienced carrier. At the Los Angeles-based agency where Ms. Wippler now works as the director of surrogate admission, the range falls between $30,000 and $60,000, which is typical across the industry in the United States, she said."

**************

Earlier post: 

Wednesday, April 22, 2020

Monday, February 15, 2021

Multiple queues for Covid vaccines, as pharmacies join the supply chain

 It is good news that pharmacies are now being included among the places that can dispense Covid vaccinations, because not everyone is connected to another kind of health care provider.  But it will not end the congestion in getting appointments and delivering vaccines.

Having multiple waiting lists for appointments--i.e. for appointments at different pharmacy chains, health care providers, county vaccination centers--will add to congestion. People will have incentives to make appointments with more than one provider, because supplies at each provider are uncertain, so that some appointments may be cancelled due to shortages of vaccine on the appointed date.  After getting vaccinated, at least some people will neglect to cancel their other appointments, and so some doses of vaccine will not be delivered when scheduled. (Hopefully they won't be wasted).  So vaccinations will still be slower than we might hope.

Here's a CBS report:

Pharmacies now offering COVID-19 vaccines: Here's what you need to know BY KATE GIBSON

"The federal government this week started sending supplies of COVID-19 vaccines to 21 national drugstore chains and to independent pharmacies in a move to accelerate distribution. The program will be implemented in stages, based on available vaccine supplies, according to the U.S. Centers for Disease Control and Prevention.

...

"National drugstore chains CVS Health and Walgreens are among those getting supplies of COVID-19 vaccines from the federal government. But getting a shot isn't as easy as walking through the pharmacy door. Consumers are instead being discouraged from flocking to the stores, but rather get in line by making an appointment online or the phone. "

***************

Here's the CDC site:

Pharmacies Participating in the Federal Retail Pharmacy Program

Sunday, February 14, 2021

Margo St. James, (1937-2021) fought to make sex work safer, and legal

 The NY Times has the story

Margo St. James, Advocate for Sex Workers, Dies at 83.  She founded a group called COYOTE (Call Off Your Old Tired Ethics) and devoted her life to the cause of decriminalizing prostitution.

"Ms. St. James sought to reframe prostitution as a profession with legitimate workplace and human rights issues rather than as something sinful. (An ally, Carol Leigh, coined the term “sex worker” in the early 1980s, and Ms. St. James helped popularize it.)

"“There is no immorality in prostitution,” she would often say. “The immorality is the arrest of women as a class for a service that’s demanded of them by society.”

"A media-savvy activist, Ms. St. James invested her crusade with showmanship. She organized an annual Hooker’s Ball, a fund-raising event that celebrated sex workers and drew politicians, police officers and movie stars. The balls reached their zenith in 1978 with 20,000 attendees filling the Cow Palace in San Francisco.

...

"She also established a free health clinic, the St. James Infirmary, which was run by and for sex workers in the Bay Area — one of the first of its kind in the world."

**********

Here is the St. James Infirmary, "a peer-based occupational health and safety clinic for sex workers of all genders.

"It is our mission to meet the needs of people engaged in the sex trade through advocacy, direct services, and social justice."

Along with providing medical care, they host a "Bad Date List" on their website: "The Bad Date List is a community-based violence intervention tool utilized by sex workers to share information regarding “bad dates.” A Bad Date may be any person who threatens, behaves violently towards, robs, extorts, or engages in any behavior that violates the agreed upon terms and boundaries of the exchange. This list may also be used to report bad encounters with law enforcement."

Saturday, February 13, 2021

Surrogacy still repugnant (and illegal) in Michigan

Michigan is now one of only a handful of U.S. states that criminalize commercial surrogacy and/or don't recognize (or severely restrict) parental rights in gestational surrogacy. The NY Times has the story about Michigan resident surrogate parents of twins, from their own eggs and sperm, who have to jump through hoops to adopt them.

Couple Forced to Adopt Their Own Children After a Surrogate Pregnancy. Tammy and Jordan Myers will have to adopt their twins after two Michigan judges denied them parental rights because the children had been carried by a surrogate.  By Maria Cramer

"Twice, judges have denied their requests to be declared the legal parents of the twins, even though a fertility doctor said in an affidavit that the babies are the couple’s biological children. In separate affidavits, the surrogate and her husband have agreed that the Myerses are the parents of the twins.

"The Myerses have started the adoption process, which will entail home visits from a social worker, personal questions about their upbringing and their approach to parenting, and criminal background checks. They said they have already submitted their fingerprints.

...

In 2020, New York passed a law that lifted its ban against compensating women who act as surrogates. Louisiana prohibits compensating surrogates but recognizes agreements or contracts in which a woman has volunteered to be a surrogate, Mr. Vaughn said. The state allows such agreements only for married heterosexual couples.

"But Michigan has a far-reaching law that does not recognize any agreement with a woman who agrees to be inseminated or implanted with an embryo, he said. The law also does not recognize the parental rights of the intended parents.

...

"Under Michigan’s law, paying a woman to act as a surrogate is a felony punishable by up to five years in prison and a $50,000 fine, said Melissa Neckers, the lawyer for the couple.

...

"In 2015, the Myerses were trying to have a second child when Ms. Myers, 39, learned she had breast cancer. She immediately had her eggs harvested before undergoing multiple surgeries, including a partial hysterectomy and a bilateral mastectomy.

...

"In a post on Facebook, the couple described their story and need to find an unpaid volunteer who would be willing to help them have a baby. Ms. Vermilye, 35, who also lives in Grand Rapids, read the post and sent them a note saying she was interested.

“My husband and I had talked about how I had a gift of carrying and delivering very easily,” said Ms. Vermilye, who has a girl and a boy who are 6 and 9. “We felt like it was kind of unfair that we had it so easy and have friends and family that don’t."

**************

The United States Surrogacy Law Map.  State-by-State Gestational Surrogacy Law & Statutes

Friday, February 12, 2021

European Network for Collaboration on Kidney Exchange Conference next Friday

 David Manlove writes to announce a conference on kidney exchange next Friday, via Zoom, on Central European Time:

"Day of talks on kidney exchange (ENCKEP Final Action Conference) - Friday 19 February

The Final Conference of the ENCKEP COST Action (European Network for Collaboration on Kidney Exchange Programmes) will take place on Friday 19 February 2021, showcasing results from the Action and featuring external speakers.  See https://www.enckep-cost.eu/ and https://www.cost.eu/actions/CA15210 for more information about ENCKEP.  Some talks may be of interest to a wider audience, hence we are advertising this event beyond ENCKEP.

Please register via https://www.eventbrite.co.uk/e/enckep-action-conference-and-training-school-tickets-138925575135 to obtain the Zoom link.

Schedule: all timings are Central European Time (CET), GMT+1 

Friday 19 February, Morning

0930-1000: Fairness models for multi-agent kidney exchange programmes, Xenia Klimentova, Ana Viana, João Pedro Pedroso, Nicolau Santos

1000-1030: Novel Integer Programming models for the stable kidney exchange problem, Xenia Klimentova, Péter Biró, Ana Viana, Virginia Costa, João Pedro Pedroso

1030-1100: New algorithms for hierarchical optimisation in kidney exchange programmes, Maxence Delorme, Sergio García, Jacek Gondzio, Joerg Kalcsics, David Manlove and William Pettersson

1100-1130: break

1130-1200: Measuring the gains of the participation of compatible pairs to  kidney exchange programs at a local level, Péter Biró, Radu Mincu, Lucrezia Furian, Antonio Nicolò

1200-1230: Long term simulation analysis of deceased donor initiated chains in kidney exchange programs, Utkarsh Verma, Narayan Rangaraj

Friday 19 February, Afternoon

1400-1430: Demonstration of the ENCKEP simulator, Xenia Klimentova / Péter Biró

1430-1500: Presentation of ENCKEP simulator results, Christian Jacquelinet

1500-1515: Transnational collaboration: the Scandiatransplant Exchange Programme, Tommy Andersson

1515-1530: Transnational collaboration involving the Czech Republic, Austria and Israel, Jiří Froněk

1530-1600: break

1600-1615: Transnational collaboration: the Australian and New Zealand Paired Kidney Exchange (ANZKX) Programme, Paolo Ferrari

1615-1645: Maintaining KPD while building LPE during a pandemic: the U.S. Experience, Ruthanne Leishman


Best regards,

David Manlove (ENCKEP Chair)"


Thursday, February 11, 2021

Economics at the extremes (of gender and salary): UC Berkeley report

 This report includes two figures in which the discipline of Economics is near one of the extremes.  The regression models on gender and salaries are interesting too.

UC BERKELEY FACULTY SALARY EQUITY STUDY, ANNUAL UPDATE, 2020  OFFICE OF THE VICE PROVOST FOR THE FACULTY, DECEMBER 2020





Wednesday, February 10, 2021

Equity v. efficiency in vaccination

Here's a sad story from the NY Times, as we struggle with getting people vaccinated, while making sure that everything is fair and square:

The Vaccine Had to Be Used. He Used It. He Was Fired.  By Dan Barry

"The Texas doctor had six hours. Now that a vial of Covid-19 vaccine had been opened on this late December night, he had to find 10 eligible people for its remaining doses before the precious medicine expired. In six hours.

...

"The doctor figured that if he returned the open vial to his department’s almost certainly empty office at this late hour, it would go to waste. So as he started the drive to his home in a neighboring county, he said, he called people in his cellphone’s contact list to ask whether they had older relatives or neighbors needing to be immunized.

...

"The next morning, he said, he submitted the paperwork for the 10 people he had vaccinated the previous night, including his wife. He said he also informed his supervisor and colleagues of what he had done, and why.

"Several days later, the doctor said, that supervisor and the human resources director summoned him to ask whether he had administered 10 doses outside of the scheduled event on Dec. 29. He said he had, in keeping with guidelines not to waste the vaccine — and was promptly fired.

"The officials maintained that he had violated protocol and should have returned the remaining doses to the office or thrown them away, the doctor recalled."


London Metals Exchange proposes to end in-person trading

 Another colorful market mechanism looks set to bite the dust, replaced by electronic/computerized trading.

The WSJ has the story:

After 144 Years, London Metal Exchange Proposes Closing Trading Ring  By Joe Wallace

"The London Metal Exchange is proposing closing its open-outcry ring, where traders have swapped metals like copper and lead using shouts and hand signals for 144 years, in a bid to attract more financial players.

"The LME temporarily closed the ring when Covid-19 ripped through the U.K. in March, judging the tight circle of red couches that dozens of traders crowd around to be a health risk. The exchange, owned by Hong Kong Exchanges & Clearing Ltd. 388 3.94% , is now proposing shutting it for good.

"The ring began life when the LME was founded above a London hat shop in 1877, though its origins date to sawdust circles around which merchants bought and sold metals in the early 1800s,

...

"If the change goes through, the LME would join CME Group’s New York Mercantile Exchange, which closed its open-outcry trading floor in lower Manhattan in 2016. The LME said it planned to lay out its next steps by the end of June after feedback from market participant

...

"Trading in the ring takes place in frenetic five-minute sessions. To avoid miscommunication amid the hubbub, dealers use hand signals to convey orders. Three fingers facing down, for example, indicates that they would like to sell metal for a price ending in three. It is assumed that every dealer knows the previous digits.

"Though much trading had migrated to the LME’s electronic platform before the pandemic, many market participants still routed orders through ring members. Some thought that open-outcry remained the best way to set closing prices that are used as reference points in metal contracts globally"

Tuesday, February 9, 2021

Understanding Big Data:Data Calculus In The Digital Era : report from the Luohan Academy

 Here's a new report from the Luohan Academy

Understanding Big Data:Data Calculus In The Digital Era   Feb 05, 2021 

Authors

Luohan Community: Patrick Bolton, Bengt Holmström, Eric Maskin, Sir Christopher Pissarides, Michael Spence, Tao Sun, Tianshu Sun,Wei Xiong, Liyan Yang

In-house: Long Chen, Yadong Huang, Yong Li, Xuan Luo, Yingju Ma, Shumiao Ouyang, Feng Zhu

From the foreword: "The pervasive use of digitized information has reached a new height that we call the era of "big data." While this has led to unprecedented societal cooperation, it has also intensified three major concerns: How can we properly protect personal privacy in the age of big data? How do we understand and manage the ownership and distribution of benefits and risks arising from the use of data? Will the use of big data lead to "winner-take-all" markets that undermine competition to the detriment of consumers and society? "

From the conclusion: "While acknowledging the challenges of privacy and data security risks, we have explored how such risks can be effectively and efficiently managed through a middle ground of government and industry self-regulation. With the right design of mechanisms and technologies, it has become increasingly possible to maintain anonymity, collect and share data while avoiding the sharing of personally identifiable information and reducing privacy and security risks, while still allowing data to freely flow. With the right technologies, the benefits of data sharing do not have to conflict with unacceptable risks to privacy. There is a way forward to capture the enormous benefits of big data while mitigating its risks, the goal of efficient and effective privacy protection. 

"One major issue is data ownership. Giving ownership of data to users who are the subjects of the data may seem like a natural safeguard of privacy. But exclusive ownership would run up against the efficient use of data as a non-rivalry good. In practice, individuals are seldom willing to make the effort of producing and recording data. In the language of economists, the private provision of a public good is generally inefficient. In addition, most people on the street do not have the capacity to mine and create big data for innovation. Data producers -- engineers at information technology firms -- do.

...

"We conclude by recommending the following three principles for governing the market for digital data:

Principle 1: Data ownership by data producers (including data subjects as producers) should be predicated on data integrity, anonymity, and especially the protection of personal and societal privacy.

Principle 2: Privacy protection and data security can to a large extent be achieved by combining state-of-the-art technologies and innovative mechanism designs.

Principle 3: Competition and consumer protection analyses of and policy prescriptions for data-driven markets should take into account the documented pro-competitive and pro-consumer benefits of big data along with any potential for anti-competitive and anti-consumer effects in specific markets."

Monday, February 8, 2021

Repugnant speech: the NYT and the "N word"

 NPR has the story:

Two Prominent 'New York Times' Journalists Depart Over Past Behavior  by David Folkenflik   February 6

"Two widely heralded journalists for The New York Times departed the paper Friday after unrelated episodes of their past behavior received sharp new scrutiny from other media outlets, readers and colleagues.

"Donald McNeil Jr., recognized as one of the nation's leading reporters on COVID-19, left after fallout from the disclosure in The Daily Beast that he had used a racial slur during a New York Times-sponsored trip for high school students. The revelation of his use of the N-word, which he said came in response to a student's query about the appropriateness of the word in a young friend's video, stirred a formal protest among more than 100 of his peers in the newsroom.

...

"In his parting letter to colleagues, McNeil said he had used a racial slur in a context that he had thought defensible at the time, but now realizes was not.

"I was asked at dinner by a student whether I thought a classmate of hers should have been suspended for a video she had made as a 12-year-old in which she used a racial slur. To understand what was in the video, I asked if she had called someone else the slur or whether she was rapping or quoting a book title. In asking the question, I used the slur itself.

...

"In a joint letter to the newsroom, Baquet and Kahn said, "We do not tolerate racist language regardless of intent." They pledged to better define and enforce guidelines on workplace behavior, including "red-line issues on racist language."

Sunday, February 7, 2021

Financing drug discovery

 Bloomberg has a nice story about financial innovation in funding drug discovery startups:

Out of Grief, MIT’s Andrew Lo Invented a Better Way to Finance Biomedical Innovation.  A company he inspired, BridgeBio Pharma, is worth $9 billion and is creating cures for orphan diseases   by Peter Coy

"The main factor in the dearth of financing, Lo realized, was the lack of diversification. Let’s say a drug costs $200 million to develop and has only a 5% chance of success. If it does succeed after 10 years of development, it could earn $2 billion a year annually for 10 years. Intriguing, but too much of a lottery ticket for most investors. 

"But what if you could raise $30 billion to fund 150 startups at once? If the success of each was independent—that is, uncorrelated with the success of any other drug in the portfolio—then the chance of at least three becoming blockbusters was 98% and the chance of at least five becoming blockbusters was 87%. Those odds were so attractive, Lo realized, that even conservative fixed-income investors who like single-A-rated bonds would be willing to finance such a fund.

"Lo had been lecturing and publishing papers along these lines for several years when a former student, Neil Kumar, told him he wanted to put Lo’s ideas into practice in a company that would focus on treatments for orphan diseases caused by single-gene defects and cancers with clear genetic drivers. It was a perfect test of the concept because each rare disease was unique; their causes were uncorrelated, as in Lo’s thought experiment.

"Lo made a small investment and was listed as a co-founder of what became BridgeBio Pharma Inc. in Palo Alto, Calif. According to Bloomberg data, the company had a market value of $9.3 billion as of Feb. 4, making Kumar’s 5.6% stake worth more than $500 million. In the webinar, Lo said, “I’m most proud of the fact that they have 20 projects of which four are in Phase 3 trials.” The company anticipates approval of one by the end of 2021 and another by the end of 2022, he said, adding, “These are therapies that would not have been developed” if not for BridgeBio."

Saturday, February 6, 2021

Kidney black market at an Afghan hospital

 The NY Times reports today on an Afghan hospital at which people in need of a transplant can buy a kidney.  The report focuses on apparently poor after-care for donors, who are interviewed recovering in nearby apartments.  It would be interesting to know more about how that compares to the situation in neighboring Iran, where there is a legal monetary market for kidneys for transplant.

In Afghanistan, a Booming Kidney Trade Preys on the Poor. Widespread poverty and an ambitious private hospital are helping to fuel an illegal market — a portal to new misery for the country’s most vulnerable.  By Adam Nossiter and Najim Rahim

"The illegal kidney business is booming in the western city of Herat, fueled by sprawling slums, the surrounding land’s poverty and unending war, an entrepreneurial hospital that advertises itself as the country’s first kidney transplantation center, and officials and doctors who turn a blind eye to organ trafficking.

...

"For the impoverished kidney sellers who recover in frigid, unlit Herat apartments of peeling paint and concrete floors, temporarily delivered from crushing debt but too weak to work, in pain and unable to afford medication, the deal is a portal to new misery. In one such dwelling, a half-sack of flour and a modest container of rice was the only food last week for a family with eight children.

"For Loqman Hakim Hospital, transplants are big business. Officials boast it has performed more than 1,000 kidney transplants in five years, drawing in patients from all over Afghanistan and the global Afghan diaspora. It offers them bargain-basement operations at one-twentieth the cost of such procedures in the United States, in a city with a seemingly unending supply of fresh organs.

...

"On the fourth floor of the hospital, three out of four patients in recovery said they had bought their kidneys.

“I feel fine now,” said Gulabuddin, a 36-year-old imam and kidney recipient from Kabul. “No pain at all.” He said he had paid about $3,500 for his kidney, bought from a “complete stranger,” with an $80 commission to the broker."

...

"“My father would have died if we had not sold,” said Jamila Jamshidi, 25, sitting on the floor across from her brother, Omid, 18, in a frigid apartment near the city’s edge. Both had sold their kidneys — she, five years ago, and he, one year ago — and both were weak and in pain."

Friday, February 5, 2021

Senate Finance Committee subpoenas UNOS

 There's a new sheriff in town in Washington, and Congress is taking note by investigating UNOS, the United Network for Organ Sharing, which is in charge of administering the allocation of deceased organs for transplant.

The United States Senate Committee on Finance yesterday issued the following announcement:

Grassley, Wyden Subpoena the United Network for Organ Sharing as part of Continued Investigation into U.S. Organ Transplant System

Washington – Senate Finance Committee leaders Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.) yesterday issued a subpoena to the United Network for Organ Sharing (UNOS), compelling production of documents related to the committee’s investigation of organ procurement organizations (OPOs), and potential false claims submitted to government benefit programs. The Committee determined that issuing a subpoena was necessary in order to receive full and complete production from UNOS.

 

Senators Grassley and Wyden issued the following joint statement:

 “We have serious concerns related to UNOS’ role in overseeing our nation’s OPOs, which have been severely underperforming for decades. Our review has shed light on the improper use of Medicare funds, conflicts of interest and gaps in oversight. UNOS has served as the federal government’s contractor, without competition, since 1986, and is responsible for overseeing the Organ Procurement and Transplantation Network established by Congress. UNOS has indicated they will comply with the subpoena and we look forward to continuing our inquiry.”

 "Senate Finance Committee members began inquiries into organ procurement organizations and UNOS, nearly a year ago. Reports have also detailed various gaps and conflicts in UNOS management of the organ donation system, resulting in a failure to properly ensure an effective system operating on behalf of patients across the country.

 "In November 2020, the Department of Health and Human Services (HHS) issued a Final Rule to impose new transparency guidelines on OPOs. Racial equity experts have lauded these OPO reforms, highlighting that OPOs often provide substandard care to patients of color. And given expert projections that COVID-19 may severely increase the demand for kidney transplants in the coming years, it is more important than ever to ensure the OPO system is functioning effectively and in patients’ interests. 

Thursday, February 4, 2021

The demand for a uterus transplant among transgender women (a survey study)

 A couple of years ago I gave a Department of Surgery Grand Rounds (a dawn seminar) at Stanford. Much later in the day, at dinner with transplant surgeons and others, someone asked me what other kinds of work I did.  So I started to tell them about my work on repugnant transactions and controversial markets, and used surrogacy as my main example. I pointed out that Sweden, where surrogacy is illegal, had pioneered uterus transplantation as an alternative that worked for some. But I suggested it wouldn't work for same-sex male couples, who are among those who use the well established legal market for surrogates in California.  The conversation quickly turned to why I was wrong.  As I recall what they said, the uterus is just a muscle, so could be transplanted into a man. Ovaries would be a problem, so in-vitro fertilization (IVF) would be needed to start the pregnancy, and of course the baby would have to be delivered via a C-section...

Since then, uterus transplantation has become somewhat more widespread, from both living and deceased donors.  As far as I know, no one is actually proposing to transplant a uterus into a man--for one thing, the demand may not be there.  But that's not the case with another group of people born without a uterus, namely transgender women.

Here's a recent survey from JAMA on just that, which shows that in fact there are transgender women who are open to bearing a child through a uterus transplant:

Jones BP, Rajamanoharan A, Vali S, et al. Perceptions and Motivations for Uterus Transplant in Transgender Women. JAMA Netw Open. 2021;4(1):e2034561. doi:10.1001/jamanetworkopen.2020.34561

"Key Points

"Question  What are the perceptions and motivations of transgender women for uterus transplant?

"Findings  This survey study of 182 transgender women found that to more than 90% of the respondents indicated that uterus transplant may improve quality of life in transgender women, alleviate dysphoric symptoms, and enhance feelings of femininity.

"Meaning  This report on the desire and willingness of transgender women to undergo uterus transplant may support the need for further animal and cadaveric model research, which is necessary to assess the feasibility of performing this procedure in transgender women"

Wednesday, February 3, 2021

Non-Simultaneous Kidney Exchange Cycles in India: new design, in Transplant International by Kute and Rees et al.

 Perhaps the biggest part of the ongoing design of kidney exchange around the world involves adapting to constantly changing local conditions in patient and donor populations, and the prevailing laws, regulations and medical situation.  In India, where non-directed donation is illegal (except in Kerala), this means that some patients can be transplanted only if long exchange cycles are possible.  In most of the world, the requirement that the surgeries in a cycle be performed simultaneously has prevented this.

The paper below, organized by two of the world's most innovative transplant doctors, Vivek Kute and Mike Rees (first and last authors, in the medical manner), demonstrates a path forward in India. The paper reports 17 very carefully arranged and conducted non-simultaneous (and non-anonymous) kidney exchange cycles, accomplishing 67 transplants. These were performed at the  Trivedi Institute of Transplantation Sciences  (using our software:).

Vivek B. Kute, Himanshu V. Patel, Pranjal R. Modi, Sayyad J. Rizvi, Pankaj R. Shah, Divyesh P Engineer, Subho Banerjee, Hari Shankar Meshram, Bina P. Butala, Manisha P. Modi, Shruti Gandhi, Ansy H. Patel, Vineet V. Mishra, Alvin E. Roth, Jonathan E. Kopke, Michael A. Rees, “Non-simultaneous kidney exchange cycles in resource-restricted countries without non-directed donation,” Transplant International, February 2021.


Abstract: Recent reports suggest that bridge-donor reneging is rare (1.5%) in non-simultaneous kidney exchange chains. However, in developing countries, the non-directed donors who would be needed to initiate chains are unavailable, and furthermore, limited surgical space and resources restrain the feasibility of simultaneous kidney exchange cycles. Therefore, the aim of this study was to evaluate the bridge-donor reneging rate during non-simultaneous kidney exchange cycles (NSKEC) in a prospective single-center cohort study (n=67). We describe the protocol used to prepare co-registered donor-recipient pairs for non-simultaneous surgeries, in an effort to minimize the reneging rate. In addition, in order to protect any recipients who might be left vulnerable by this arrangement, we proposed the use of standard criteria deceased-donor kidneys to rectify the injustice in the event of any bridge-donor reneging.  We report 17 successful NSKEC resulting in 67 living-donor kidney transplants (LDKT) using  23 bridge-donors without donor renege  and  no intervening pairs became unavailable. We propose that NSKEC could increase LDKT, especially for difficult-to-match sensitized pairs (25 of our 67 pairs) in countries with limited transplantation resources. Our study confirms that NSKEC can be safely performed with careful patient-donor selection and non-anonymous kidney exchanges.



**************
Some previous posts:

Tuesday, February 2, 2021

Vaccination (and mask wearing) as repugnant transactions

 If a repugnant transaction is one that some people want to participate in, and other people think they shouldn't be allowed to (even those others aren't harmed by the participation of those who want to), then both vaccination and mask wearing are repugnant transactions, as Trumpism continues to work its way through the body politic.

Here's a story from the LA Times:

Dodger Stadium’s COVID-19 vaccination site temporarily shut down after protesters gather at entrance By MARISA GERBER, IRFAN KHAN

"Dodger Stadium’s mass COVID-19 vaccination site was temporarily shut down Saturday afternoon when about 50 protesters gathered at the entrance, frustrating hundreds of motorists who had been waiting in line for hours.

...

"The demonstrators included members of anti-vaccine and far-right groups. While some carried signs decrying the COVID-19 vaccine and shouting for people not to get the shots, there were no incidents of violence.

...

"A post on social media described the demonstration as the “Scamdemic Protest/March.” It advised participants to “please refrain from wearing Trump/MAGA attire as we want our statement to resonate with the sheeple. No flags but informational signs only.

“This is a sharing information protest and march against everything COVID, Vaccine, PCR Tests, Lockdowns, Masks, Fauci, Gates, Newsom, China, digital tracking, etc.”

...

"Protesters carried signs that read “Save Your Soul TURN BACK NOW,” “CNN IS LYING TO YOU,” “RECALL GAVIN NEWSOM” and “TAKE OFF YOUR MASK.”

...

“Unbelievable,” Los Angeles City Council President Nury Martinez tweeted. “If you don’t want the vaccine fine, but there are millions of Angelenos that do. 16,000 of your neighbors have died, so get out of the way.”

Monday, February 1, 2021

Economics and Engineering (and market design): some history and prehistory, at Stanford and elsewhere

The  December 2020 issue of History of Political Economy is devoted to Economics and Engineering.

Here's an account of Stanford and Bob Wilson (among others), written before the most recent Nobel prize to Wilson and Milgrom.

A Century of Economics and Engineering at Stanford by Beatrice Cherrier and Aurélien Saïdi

History of Political Economy (2020) 52 (S1): 85–111.  https://doi.org/10.1215/00182702-8717936

"This article documents the disciplinary exchanges between economists and engineers at Stanford throughout the twentieth century. We outline the role of key scholars such as Kenneth Arrow and Robert Wilson, as well as engineers turned administrators like Frederick Terman. We show that engineers drew upon economic theories of decision and allocation to improve practical industrial management decisions. Reciprocally, economists found in engineering the tools that they needed to rethink production and growth theory (including linear programming, optimal control theory, an epistemology of “application” that emphasized awareness to institutional details, trials and errors and experiments). By the 2000s, they had turned into economic engineers designing markets and other allocation mechanisms. These cross-disciplinary exchanges were mediated by Stanford’s own institutional culture, notably its use of joint appointments, the development of multidisciplinary “programs” for students, the ability to attract a variety of visitors every year, the entrepreneurial and contract-oriented vision of its administrators, and the close ties with the industrial milieu that came to be called the Silicon Valley.

..

"This article should not be read as a history of economics, engineering, or management science at Stanford and their idiosyncrasies.4  None of the research programs or institutional arrangements we describe were unique to Stanford. Rather, we document how some of the engineering and economics theories, tools, and epistemologies developed elsewhere were recombined in a specific institutional setting and entrepreneurial culture, and thus came to infuse the vision that some Stanford economists developed and spread in the last decades."

************

The pdf to the full article appears to be ungated, and will be especially rewarding to old Stanford hands, who will recognize a lot of names from Operations Research as well as from Econ.

************

And here's the introduction to the whole December special issue, by its editors:

Introduction: From “Economics as Engineering” to “Economics and Engineering”  by Pedro Garcia Duarte and Yann Giraud

History of Political Economy (2020) 52 (S1): 10–27.  https://doi.org/10.1215/00182702-8717898

"Economists such as Alvin Roth and Esther Duflo have recently argued that economics in the late twentieth century has evolved from (social) science to engineering. On the other hand, historians such as Mary Morgan and Michel Armatte have argued that the transformation of economics into an engineering science has been a century-long development. Turning away from the “economics as engineering” analogy, our introduction suggests an alternative approach to account for the presumed transformation of economics into an engineering science. We encourage the development of a history of “economics and engineering,” which depicts how these two types of knowledge–and the communities who produce them–have interacted in various institutional and national contexts. Drawing on the contributions to this 2020 annual supplement of HOPE, we show how these narratives may help change the historiography of twentieth-century economics."

*************

As it happens, I had the privilege of discussing some of these papers  in Atlanta in  2019 at the ASSA meetings, in a session sponsored by  the History of Economics Society, and chaired by Pedro Garcia Duarte.

Another paper from that session that appears in this issue of HOPE is 

Engineering the “Statistical Control of Business”: Malcolm Rorty, Telephone Engineering, and American Economics, 1900–1930  by Thomas A. Stapleford

History of Political Economy (2020) 52 (S1): 59–84.  https://doi.org/10.1215/00182702-8717924

"Malcolm Rorty is best known to historians of economics as the primary organizer and founder of the National Bureau of Economic Research. This article situates Rorty’s interest in economics against the backdrop of his early career in telephone engineering at American Telephone & Telegraph. I argue that distinct structural features of telephone engineering in general, and AT&T in particular, created overlaps between the practices of engineering and economics, and also opened space for Rorty to craft a broader vision for the “statistical control of business” through quantitatively informed management."

Sunday, January 31, 2021

Paying employees to be vaccinated against Covid. (Is that repugnant? Could it be illegal??)

 Apparently paying workers to get vaccinated (even giving them paid time off to get vaccinated) may face some legal complications.

The Washington Post has the story:

Why grocery chains are paying workers to get vaccinated, but other industries are lagging   by By Jena McGregor and Taylor Telford

"A number of leading grocery chains are offering small cash bonuses and other incentives to encourage employees to get the coronavirus vaccine, in an effort that experts say could help speed protection of some of the country’s most vulnerable workers: low-paid, hourly retail workers.

"Dollar General, Trader Joe’s, Aldi and Lidl, as well as Instacart, have announced plans to promote the vaccine among employees, including flexible work schedules, paid time off to visit a vaccination site and bonuses of up to $200.

"The restaurant industry may also be moving toward incentives. On Tuesday, Darden Restaurants, which employs more than 175,000 workers across Olive Garden, LongHorn Steakhouse and many more brands, said it would offer up to four hours of paid time off to get the vaccine.

"However, few other companies have followed suit, potentially in part because of legal uncertainties involved with health screening questionnaires leading up to vaccination.

...

"Some lawyers believe companies will be able to successfully argue that the required screening questions for the coronavirus vaccine meet the standard of being needed for the business. 

...

"But others say the screening questions could complicate things if they’re seen as being part of a “voluntary wellness program,” which may limit the incentives companies can offer. If the employer contracts with an outside firm to vaccinate employees or has its own staff inoculate workers, new proposed rules from the U.S. Equal Employment Opportunity Commission, which says incentives can only be “de minimus” in size, might apply. The proposed rules give examples like a water bottle or gift card of “modest value.”

**********

Update: here's a related story from the Financial Times, focusing on the fact that there may be a shortage of vaccinated employees for some time:

Should Covid vaccines be mandatory at work? A few companies have introduced ‘no jab, no job’ policies, but it is unclear if such steps are lawful by Pilita Clark and Emma Jacobs


Saturday, January 30, 2021

Mechanism design conference (virtually) at Pitt, April 15-17, with keynotes by Tuomas Sandholm and Utku Unver

 Here's the announcement: the conference is sponsored by the NBER

Mechanism Design for Vulnerable Populations

Thurs Apr 15- Sat Apr 17, 2021

Graduate School of Public and International Affairs (GSPIA)

University of Pittsburgh

"We are delighted to share that the NSF/CEME Decentralization 2021 conference, which had to be postponed from 2020 due to COVID-19, will take place virtually on April 15-17 this year! This conference series is funded by the National Science Foundation and is administered through the National Bureau of Economic Research (NBER). This is the 50th anniversary of the Decentralization conference - the first Decentralization Conference was held at UC Berkeley in 1971.

"The goal of this year's conference is to apply and extend mechanism design to the practical needs of institutions that serve vulnerable populations. These populations pose conceptual and technical challenges for the designer due to the high stakes decision making environments, complex constraints on agents’ action space, and the cumulative effects of disadvantaged participation in previous mechanisms. We are excited to have Tuomas Sandholm (Carnegie Mellon University) and M. Utku Unver (Boston College) as keynote speakers.

"Talks (including discussions) are 30-45 minutes and spans general mechanism design theory as well as topics such as matching and assignment problems in foster care, refugee resettlement, low-income housing, affirmative action, and criminal justice. Each talk will be followed by an open chat with the audience and two discussants - for session #2-5 this will be an academic and a practitioner. Breakout groups at the end of each module allows for more substantial engagement with each topic."

 

Friday, January 29, 2021

Vaccine delivery in the U.S. continues to be congested

As of today, congestion is still competing with short supply to limit vaccination in the US.

Some doses are being wasted or delayed in the name of fairness,  to better honor the priority orderings being used in each state, some doses are being sequestered for second vaccinations rather than being used now for first vaccinations, and some regions and/or providers have too little vaccine on hand, or too little predictability of supply to plan efficient distribution.

 USA today has the story:

Amid sputtering COVID-19 vaccine rollout, 16 states have used less than half of distributed doses  by Ken Alltucker

"The Biden administration has vowed drug companies will make enough vaccine to immunize 300 million Americans by the end of the summer.

But getting the vaccine from the factory to the arms of people has been anything but smooth. Of 47.2 million doses shipped to states and nursing homes, 24.6 million doses have been administered, the Centers for Disease Control and Prevention reported Thursday. 

The nation's slow rollout has boiled over from California, which tapped Blue Shield of California to allocate vaccines, to Maryland where Gov. Larry Hogan implored the federal government to send more doses of the potentially life-saving vaccine.

An Arlington, Virginia, hospital canceled 10,000 vaccine appointments, citing the state's decision to send doses to county health departments rather than directly to hospitals and other health providers.  In Minnesota, a vaccine lottery offered just 8,000 appointments to more than 226,000 people who signed up over a 24-hour period this week."